Invention Application
- Patent Title: AZAINDAZOLES AS KINASE INHIBITORS AND USE THEREOF
- Patent Title (中): AZAINDAZOLES作为激酶抑制剂及其用途
-
Application No.: US13388700Application Date: 2010-08-11
-
Publication No.: US20120129852A1Publication Date: 2012-05-24
- Inventor: Jingwu Duan , Bin Jiang , Zhonghui Lu
- Applicant: Jingwu Duan , Bin Jiang , Zhonghui Lu
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- International Application: PCT/US2010/045109 WO 20100811
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/496 ; A61K31/5377 ; A61K31/497 ; A61P29/00 ; A61K31/519 ; A61P35/00 ; A61P37/08 ; A61P37/00 ; C07D471/04 ; C07D487/04
Abstract:
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, (I) are useful as kinase modulators, including Btk modulation, wherein A1, A2, A3, R4 are as defined herein.
Public/Granted literature
- US08846673B2 Azaindazoles as kinase inhibitors and use thereof Public/Granted day:2014-09-30
Information query
IPC分类:
